Skandinaviska Enskilda Banken (SEB)’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-42,400
| Closed | -$416K | – | 908 |
|
|
2023
Q4 | $416K | Sell |
42,400
-22,800
| -35% | -$224K | ﹤0.01% | 790 |
|
|
2023
Q3 | $544K | Sell |
65,200
-13,400
| -17% | -$112K | ﹤0.01% | 754 |
|
|
2023
Q2 | $1.05M | Buy |
78,600
+25,500
| +48% | +$339K | 0.01% | 690 |
|
|
2023
Q1 | $615K | Buy |
+53,100
| New | +$615K | ﹤0.01% | 752 |
|
|
2022
Q1 | – | Sell |
-24,505
| Closed | -$512K | – | 1046 |
|
|
2021
Q4 | $512K | Hold |
24,505
| – | – | ﹤0.01% | 843 |
|
|
2021
Q3 | $626K | Hold |
24,505
| – | – | ﹤0.01% | 847 |
|
|
2021
Q2 | $857K | Buy |
+24,505
| New | +$857K | 0.01% | 829 |
|